Atlas Trials

Neoadjuvant Phase 2 Study Comparing the Effects of AR Inhibition With/Without SRC or MEK Inhibition in Prostate Cancer

Clinical trial NCT01990196 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT01990196
Sponsor
Jonsson Comprehensive Cancer Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2014-09-23
Primary completion
2024-09-23
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.